Administration of bifidobacterium and lactobacillus strains modulates experimental myasthenia gravis and experimental encephalomyelitis in Lewis rats

Oncotarget

Volumn 9, Issue 32, 2018, Pages 22269-22287

  Consonni, Alessandra ^a   Cordiglieri, Chiara ^a   Rinaldi, Elena ^a   Marolda, Roberta ^a   Ravanelli, Ilaria ^a   Guidesi, Elena ^b   Elli, Marina ^b   Mantegazza, Renato ^a   Baggi, Fulvio ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

^b AAT Advanced Analytical Technologies Srl   (Italy)

Author keywords

Experimental autoimmune encephalomyelitis; Experimental autoimmune myasthenia gravis; Immunology; Probiotics

Indexed keywords

MYELIN; PROBIOTIC AGENT; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIFIDOBACTERIUM; BLOOD; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; DISEASE SEVERITY; DRUG EFFICACY; EX VIVO STUDY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; EXPERIMENTAL AUTOIMMUNE MYASTHENIA GRAVIS; FEMALE; IMMUNOCOMPETENCE; IMMUNOMODULATION; IMMUNOREGULATION; INTESTINE LYMPHATIC TISSUE; LACTOBACILLUS; LEWIS RAT; NEUROMUSCULAR JUNCTION; NONHUMAN; PROTEIN EXPRESSION; RAT; REGULATORY T LYMPHOCYTE; SPINAL CORD;

EID: 85046098050     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.25170     Document Type: Article

References (83)

1. Belkaid Y, Hand TW. Role of the microbiota in immunity and inflammation. Cell. 2014; 157:121-41. https://doi. org/10.1016/j.cell.2014.03.011
2. Peterson CT, Sharma V, Elmén L, Peterson SN. Immune homeostasis, dysbiosis and therapeutic modulation of the gut microbiota. Clin Exp Immunol. 2015; 179:363-77. https://doi.org/10.1111/cei.12474
3. McCarville J, Caminero A, Verdu E. Novel perspectives on therapeutic modulation of the gut microbiota. Therap Adv Gastroenterol. 2016; 9:580-93. https://doi. org/10.1177/1756283X16637819
4. Sharon G, Sampson TR, Geschwind DH, Mazmanian SK. The Central Nervous System and the Gut Microbiome. Cell. 2016; 167:915-32. https://doi.org/10.1016/j.cell.2016.10.027
5. Bauer KC, Huus KE, Finlay BB. Microbes and the mind: Emerging hallmarks of the gut microbiota-brain axis. Cell Microbiol. 2016; 18:632-44. https://doi.org/10.1111/ cmi.12585
6. Westfall S, Lomis N, Kahouli I, Dia SY, Singh SP, Prakash S. Microbiome, probiotics and neurodegenerative diseases: deciphering the gut brain axis. Cell Mol Life Sci. 2017; 74:3769-87. https://doi.org/10.1007/s00018-017-2550-9
7. Fasano A, Shea-Donohue T. Mechanisms of disease: the role of intestinal barrier function in the pathogenesis of gastrointestinal autoimmune diseases. Nat Clin Pract Gastroenterol Hepatol. 2005; 2:416-22. https://doi. org/10.1038/ncpgasthep0259
8. Fasano A. Leaky gut and autoimmune diseases. Clin Rev Allergy Immunol. 2012; 42:71-8. https://doi.org/10.1007/ s12016-011-8291-x
9. Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, Morelli L, Canani RB, Flint HJ, Salminen S, Calder PC, Sanders ME. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014; 11:506-14. https://doi.org/10.1038/nrgastro.2014.66
10. Erickson KL, Hubbard NE. Probiotic immunomodulation in health and disease. J Nutr. 2000; 130:403S-409S
11. Pfefferle PI, Prescott SL, Kopp M. Microbial influence on tolerance and opportunities for intervention with prebiotics/probiotics and bacterial lysates. J Allergy Clin Immunol. 2013; 131:1453-63. https://doi.org/10.1016/j. jaci.2013.03.020
12. Surana NK, Kasper DL. Deciphering the tête-à-tête between the microbiota and the immune system. J Clin Invest. 2014; 124:4197-203. https://doi.org/10.1172/JCI72332
13. Christensen HR, Frøkiaer H, Pestka JJ. Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J Immunol. 2002; 168:171-8
14. Di Giacinto C, Marinaro M, Sanchez M, Strober W, Boirivant M. Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells. J Immunol. 2005; 174:3237-46
15. Amati L, Marzulli G, Martulli M, Pugliese V, Caruso C, Candore G, Vasto S, Jirillo E. Administration of a symbiotic to free-living elderly and evaluation of serum cytokines. A pilot study. Curr Pharm Des. 2010; 16:854-8. https://doi. org/10.2174/138161210790883633
16. Braat H, de Jong EC, van den Brande JMH, Kapsenberg ML, Peppelenbosch MP, van Tol EAF, van Deventer SJH. Dichotomy between Lactobacillus rhamnosus and Klebsiella pneumoniae on dendritic cell phenotype and function. J Mol Med (Berl). 2004; 82:197-205. https://doi.org/10.1007/s00109-003-0509-9
17. Kwon HK, Lee CG, So JS, Chae CS, Hwang JS, Sahoo A, Nam JH, Rhee JH, Hwang KC, Im SH. Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorders. Proc Natl Acad Sci USA. 2010; 107:2159-64. https://doi. org/10.1073/pnas.0904055107
18. Dwivedi M, Kumar P, Laddha NC, Kemp EH. Induction of regulatory T cells: A role for probiotics and prebiotics to suppress autoimmunity. Autoimmun Rev. 2016; 15:379-92. https://doi.org/10.1016/j.autrev.2016.01.002
19. Boyle RJ, Tang MLK. The role of probiotics in the management of allergic disease. Clin Exp Allergy. 2006; 36:568-76. https://doi.org/10.1111/j.1365-2222.2006.02472.x
20. O'Callaghan A, van Sinderen D. Bifidobacteria and Their Role as Members of the Human Gut Microbiota. Front Microbiol. 2016; 7:925. https://doi.org/10.3389/ fmicb.2016.00925
21. Castagliuolo I, Galeazzi F, Ferrari S, Elli M, Brun P, Cavaggioni A, Tormen D, Sturniolo GC, Morelli L, Palù G. Beneficial effect of auto-aggregating Lactobacillus crispatus on experimentally induced colitis in mice. FEMS Immunol Med Microbiol. 2005; 43:197-204. https://doi. org/10.1016/j.femsim.2004.08.011
22. Kim N, Kunisawa J, Kweon M, Eog Ji G, Kiyono H. Oral feeding of Bifidobacterium bifidum (BGN4) prevents CD4(+) CD45RB(high) T cell-mediated inflammatory bowel disease by inhibition of disordered T cell activation. Clin Immunol. 2007; 123:30-9. https://doi.org/10.1016/j. clim.2006.11.005
23. So JS, Kwon HK, Lee CG, Yi HJ, Park JA, Lim SY, Hwang KC, Jeon YH, Im SH. Lactobacillus casei suppresses experimental arthritis by down-regulating T helper 1 effector functions. Mol Immunol. 2008; 45:2690-9 https://doi.org/10.1016/j.molimm.2007.12.010
24. Viljanen M, Pohjavuori E, Haahtela T, Korpela R, Kuitunen M, Sarnesto A, Vaarala O, Savilahti E. Induction of inflammation as a possible mechanism of probiotic effect in atopic eczema-dermatitis syndrome. J Allergy Clin Immunol. 2005; 115:1254-9. https://doi.org/10.1016/j. jaci.2005.03.047
25. Rather IA, Bajpai VK, Kumar S, Lim J, Paek WK, Park YH. Probiotics and Atopic Dermatitis: An Overview. Front Microbiol. 2016; 7:507. https://doi.or g/10.3389/ fmicb.2016.0050
26. Gilhus NE, Verschuuren JJ. Myasthenia gravis: Subgroup classification and therapeutic strategies. Lancet Neurol. 2015; 14:1023-36. https://doi.org/10.1016/ S1474-4422(15)00145-3
27. Matthews PM. Decade in review-multiple sclerosis: new drugs and personalized medicine for multiple sclerosis. Nat Rev Neurol. 2015; 11:614-6. https://doi.org/10.1038/ nrneurol.2015.200
28. Losen M, Martinez-Martinez P, Molenaar PC, Lazaridis K, Tzartos S, Brenner T, Duan RS, Luo J, Lindstrom J, Kusner L. Standardization of the experimental autoimmune myasthenia gravis (EAMG) model by immunization of rats with Torpedo californica acetylcholine receptors-recommendations for methods and experimental designs. Exp Neurol. 2015; 270:18-28. https://doi.org/10.1016/j. expneurol.2015.03.010
29. Mantegazza R, Cordiglieri C, Consonni A, Baggi F. Animal models of myasthenia gravis: utility and limitations. Int J Gen Med. 2016; 9:53-64. https://doi.org/10.2147/IJGM. S88552
30. Hollenbach JA, Oksenberg JR. The immunogenetics of multiple sclerosis: A comprehensive review. J Autoimmun. 2015; 64:13-25. https://doi.org/10.1016/j.jaut.2015.06.010
31. Steinman L. Assessment of animal models for MS and demyelinating disease in the design of rational therapy. Neuron. 1999; 24:511-4
32. Gold R, Linington C, Lassmann H. Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain. 2006; 129:1953-71. https://doi.org/10.1093/brain/awl075
33. Linker RA, Lee DH. Models of autoimmune demyelination in the central nervous system: on the way to translational medicine. Exp Transl Stroke Med. 2009; 1:5. https://doi. org/10.1186/2040-7378-1-5
34. Mix E, Meyer-Rienecker H, Hartung HP, Zettl UK. Animal models of multiple sclerosis-potentials and limitations. Prog Neurobiol. 2010; 92:386-404. https://doi.org/10.1016/j. pneurobio.2010.06.005
35. Pitarokoili K, Ambrosius B, Gold R. Lewis Rat Model of Experimental Autoimmune Encephalomyelitis. Curr Protoc Neurosci. 2017; 81:9. https://doi.org/10.1002/cpns.36
36. Mannie M, Swanborg RH, Stepaniak JA. Experimental Autoimmune Encephalomyelitis in the Rat. Curr Protoc Immunol. 2009; 85; Unit 15.2. https://doi. org/10.1002/0471142735.im1502s85
37. Almolda B, Costa M, Montoya M, González B, Castellano B. Increase in Th17 and T-reg lymphocytes and decrease of IL22 correlate with the recovery phase of acute EAE in rat. PLoS One. 2011; 6:e27473. https://doi. org/10.1371/journal.pone.0027473
38. Voltan S, Castagliuolo I, Elli M, Longo S, Brun P, D'Incà R, Porzionato A, Macchi V, Palù G, Sturniolo GC, Morelli L, Martines D. Aggregating phenotype in Lactobacillus crispatus determines intestinal colonization and TLR2 and TLR4 modulation in murine colonic mucosa. Clin Vaccine Immunol. 2007; 14:1138-48. https://doi.org/10.1128/ CVI.00079-07
39. Voltan S, Martines D, Elli M, Brun P, Longo S, Porzionato A, Macchi V, D'Incà R, Scarpa M, Palù G, Sturniolo GC, Morelli L, Castagliuolo I. Lactobacillus crispatus M247-derived H2O2 acts as a signal transducing molecule activating peroxisome proliferator activated receptor-gamma in the intestinal mucosa. Gastroenterology. 2008; 135:1216-27 https://doi.org/10.1053/j.gastro.2008.07.007
40. Wang Y, Kasper LH. The role of microbiome in central nervous system disorders. Brain Behav Immun. 2014; 38:1-12. https://doi.org/10.1016/j.bbi.2013.12.015
41. Boirivant M, Strober W. The mechanism of action of probiotics. Curr Opin Gastroenterol. 2007; 23:679-92. https://doi.org/10.1097/MOG.0b013e3282f0cffc
42. Guglielmetti S, Mora D, Gschwender M, Popp K. Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life-a double-blind, placebocontrolled study. Aliment Pharmacol Ther. 2011; 33:1123-32. https://doi.org/10.1111/j.1365-2036.2011.04633.x
43. Dolpady J, Sorini C, Di Pietro C, Cosorich I, Ferrarese R, Saita D, Clementi M, Canducci F, Falcone M. Oral Probiotic VSL#3 Prevents Autoimmune Diabetes by Modulating Microbiota and Promoting Indoleamine 2,3-Dioxygenase-Enriched Tolerogenic Intestinal Environment. J Diabetes Res. 2016; 2016:7569431. https:// doi.org/10.1155/2016/7569431
44. Abhari K, Shekarforoush SS, Hosseinzadeh S, Nazifi S, Sajedianfard J, Eskandari MH. The effects of orally administered Bacillus coagulans and inulin on prevention and progression of rheumatoid arthritis in rats. Food Nutr Res. 2016; 60:30876. https://doi.org/10.3402/fnr.v60.30876
45. Chae CS, Kwon HK, Hwang JS, Kim JE, Im SH. Prophylactic effect of probiotics on the development of experimental autoimmune myasthenia gravis. PLoS One. 2012; 7:e52119. https://doi.org/10.1371/journal.pone.0052119
46. Lavasani S, Dzhambazov B, Nouri M, Fåk F, Buske S, Molin G, Thorlacius H, Alenfall J, Jeppsson B, Weström B. A novel probiotic mixture exerts a therapeutic effect on experimental autoimmune encephalomyelitis mediated by IL-10 producing regulatory T cells. PLoS One. 2010; 5:e9009. https://doi.org/10.1371/journal.pone.0009009
47. Kwon HK, Kim GC, Kim Y, Hwang W, Jash A, Sahoo A, Kim JE, Nam JH, Im SH. Amelioration of experimental autoimmune encephalomyelitis by probiotic mixture is mediated by a shift in T helper cell immune response. Clin Immunol. 2013; 146:217-27. https://doi.org/10.1016/j. clim.2013.01.001
48. Elli M, Callegari ML, Ferrari S, Bessi E, Cattivelli D, Soldi S, Morelli L, Goupil Feuillerat N, Antoine JM. Survival of yogurt bacteria in the human gut. Appl Environ Microbiol. 2006; 72:5113-7. https://doi.org/10.1128/ AEM.02950-05
49. Bartosch S, Woodmansey EJ, Paterson JCM, McMurdo MET, Macfarlane GT. Microbiological effects of consuming a synbiotic containing Bifidobacterium bifidum, Bifidobacterium lactis, and oligofructose in elderly persons, determined by real-time polymerase chain reaction and counting of viable bacteria. Clin Infect Dis. 2005; 40:28-37. https://doi.org/10.1086/426027
50. Marx A, Pfister F, Schalke B, Saruhan-Direskeneli G, Melms A, Ströbel P. The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes. Autoimmun Rev. 2013; 12:875-84. https://doi. org/10.1016/j.autrev.2013.03.007
51. Cordiglieri C, Marolda R, Franzi S, Cappelletti C, Giardina C, Motta T, Baggi F, Bernasconi P, Mantegazza R, Cavalcante P. Innate immunity in myasthenia gravis thymus: Pathogenic effects of Toll-like receptor 4 signaling on autoimmunity. J Autoimmun. 2014; 52:74-89. https:// doi.org/10.1016/j.jaut.2013.12.013
52. Gertel-Lapter S, Mizrachi K, Berrih-Aknin S, Fuchs S, Souroujon MC. Impairment of regulatory T cells in myasthenia gravis: Studies in an experimental model. Autoimmun Rev. 2013; 12:894-903. https://doi. org/10.1016/j.autrev.2013.03.009
53. Nessi V, Nava S, Ruocco C, Toscani C, Mantegazza R, Antozzi C, Baggi F. Naturally occurring CD4+CD25+ regulatory T cells prevent but do not improve experimental myasthenia gravis. J Immunol. 2010; 185:5656-67. https:// doi.org/10.4049/jimmunol.0903183
54. Atarashi K, Tanoue T, Oshima K, Suda W, Nagano Y, Nishikawa H, Fukuda S, Saito T, Narushima S, Hase K, Kim S, Fritz JV, Wilmes P, et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature. 2013; 500:232-6. https://doi. org/10.1038/nature12331
55. Kverka M, Zakostelska Z, Klimesova K, Sokol D, Hudcovic T, Hrncir T, Rossmann P, Mrazek J, Kopecny J, Verdu E, Tlaskalova-Hogenova H. Oral administration of Parabacteroides distasonis antigens attenuates experimental murine colitis through modulation of immunity and microbiota composition. Clin Exp Immunol. 2011; 163:250-9. https://doi.org/10.1111/j.1365-2249.2010.04286.x
56. Flügel A, Berkowicz T, Ritter T, Labeur M, Jenne DE, Li Z, Ellwart JW, Willem M, Lassmann H, Wekerle H. Migratory Activity and Functional Changes of Green Fluorescent Effector Cells before and during Experimental Autoimmune Encephalomyelitis. Immunity. 2001; 14:547-60. https://doi. org/10.1016/S1074-7613(01)00143-1
57. Cordiglieri C, Odoardi F, Zhang B, Nebel M, Kawakami N, Klinkert WEF, Lodygin D, Lühder F, Breunig E, Schild D, Ulaganathan VK, Dornmair K, Dammermann W, et al. Nicotinic acid adenine dinucleotide phosphatemediated calcium signalling in effector T cells regulates autoimmunity of the central nervous system. Brain. 2010; 133:1930-43. https://doi.org/10.1093/brain/awq135
58. Shin T, Ahn M, Matsumoto Y. Mechanism of experimental autoimmune encephalomyelitis in Lewis rats: recent insights from macrophages. Anat Cell Biol. 2012; 45:141-8. https://doi.org/10.5115/acb.2012.45.3.141
59. Brambilla R, Morton PD, Ashbaugh JJ, Karmally S, Lambertsen KL, Bethea JR. Astrocytes play a key role in EAE pathophysiology by orchestrating in the CNS the inflammatory response of resident and peripheral immune cells and by suppressing remyelination. Glia. 2014; 62:452-67. https://doi.org/10.1002/glia.22616
60. Brambilla R, Persaud T, Hu X, Karmally S, Shestopalov VI, Dvoriantchikova G, Ivanov D, Nathanson L, Barnum SR, Bethea JR. Transgenic Inhibition of Astroglial NF-κB Improves Functional Outcome in Experimental Autoimmune Encephalomyelitis by Suppressing Chronic Central Nervous System Inflammation. J Immunol. 2009; 182:2628-40. https://doi.org/10.4049/jimmunol.0802954
61. Kobayashi T, Kato I, Nanno M, Shida K, Shibuya K, Matsuoka Y, Onoue M. Oral administration of probiotic bacteria, Lactobacillus casei and Bifidobacterium breve, does not exacerbate neurological symptoms in experimental autoimmune encephalomyelitis. Immunopharmacol Immunotoxicol. 2010; 32:116-24. https://doi. org/10.3109/08923970903200716
62. den Besten G, van Eunen K, Groen AK, Venema K, Reijngoud DJ, Bakker BM. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res. 2013; 54:2325-40. https:// doi.org/10.1194/jlr.R036012
63. Pryde SE, Duncan SH, Hold GL, Stewart CS, Flint HJ. The microbiology of butyrate formation in the human colon. FEMS Microbiol Lett. 2002; 217:133-9. https://doi. org/10.1016/S0378-1097(02)01106-0
64. Diaz Heijtz R, Wang S, Anuar F, Qian Y, Björkholm B, Samuelsson A, Hibberd ML, Forssberg H, Pettersson S. No rmal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci USA. 2011; 108:3047-52. https://doi.org/10.1073/pnas.1010529108
65. Braniste V, Al-Asmakh M, Kowal C, Anuar F, Abbaspour A, Toth M, Korecka A, Bakocevic N, Ng LG, Kundu P, Gulyas B, Halldin C, Hultenby K, et al. The gut microbiota influences blood-brain barrier permeability in mice. Sci Transl Med. 2014; 6:263ra158. https://doi.org/10.1126/ scitranslmed.3009759
66. Knieke K, Lingel H, Chamaon K, Brunner-Weinzierl MC. Migration of Th1 lymphocytes is regulated by CD152 (CTLA-4)-mediated signaling via PI3 kinase-dependent Akt activation. PLoS One. 2012; 7:e31391. https://doi. org/10.1371/journal.pone.0031391
67. Maassen CBM, Claassen E. Strain-dependent effects of probiotic lactobacilli on EAE autoimmunity. Vaccine. 2008; 26:2056-57. https://doi.org/10.1016/j.vaccine.2008.02.035
68. Arpaia N, Campbell C, Fan X, Dikiy S, van der Veeken J, DeRoos P, Liu H, Cross JR, Pfeffer K, Coffer PJ, Rudensky AY. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature. 2013; 504:451-5. https://doi.org/10.1038/nature12726
69. Van den Nieuwboer M, Brummer RJ, Guarner F, Morelli L, Cabana M, Claassen E. The administration of probiotics and synbiotics in immune compromised adults: Is it safe? Benef Microbes. 2015; 6:3-17. https://doi.org/10.3920/ BM2014.0079
70. Inoue H, Ohsawa I, Murakami T, Kimura A, Hakamata Y, Sato Y, Kaneko T, Takahashi M, Okada T, Ozawa K, Francis J, Leone P, Kobayashi E. Development of new inbred transgenic strains of rats with LacZ or GFP. Biochem Biophys Res Commun. 2005; 329:288-95. https://doi. org/10.1016/j.bbrc.2005.01.132
71. Lindstrom JM, Einarson BL, Lennon VA, Seybold ME. Pathological mechanisms in experimental autoimmune myasthenia gravis. I. Immunogenicity of syngeneic muscle acetylcholine receptor and quantitative extraction of receptor and antibody-receptor complexes from muscles of rats with experimental automimmune myasthenia gravis. J Exp Med. 1976; 144:726-38. https://doi.org/10.1084/ jem.144.3.726
72. Elliott J, Blanchard SG, Wu W, Miller J, Strader CD, Hartig P, Moore HP, Racs J, Raftery MA. Purification of Torpedo californica post-synaptic membranes and fractionation of their constituent proteins. Biochem J. 1980; 185:667-77. https://doi.org/10.1042/bj1850667
73. Bellone M, Ostlie N, Karachunski P, Manfredi AA, Conti-Tronconi BM. Cryptic Epitopes on the Nicotinic Acetylcholine Receptor Are Recognized by Autoreactive CD4+ Cells. J Immunol. 1993; 151:1025-38
74. Lindstrom J, Einarson B, Tzartos S. Production and assay of antibodies to acetylcholine receptors. Methods Enzymol. 1981; 74:432-60. https://doi. org/10.1016/0076-6879(81)74031-X
75. Cole RN, Reddel SW, Gervásio OL, Phillips WD. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction. Ann Neurol. 2008; 63:782-9. https://doi. org/10.1002/ana.21371
76. Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012; 9:671-5
77. Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B, Tinevez JY, White DJ, Hartenstein V, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012; 9:676-82. https://doi.org/10.1038/ nmeth.2019
78. Shao L, Kner P, Rego EH, Gustafsson MGL. Superresolution 3D microscopy of live whole cells using structured illumination. Nat Methods. 2011; 8:1044-6. https://doi.org/10.1038/nmeth.1734
79. Savaskan NE, Weinmann O, Heimrich B, Eyupoglu IY. High resolution neurochemical gold staining method for myelin in peripheral and central nervous system at the lightand electron-microscopic level. Cell Tissue Res. 2009; 337:213-21. https://doi.org/10.1007/s00441-009-0815-9
80. Schmued L, Bowyer J, Cozart M, Heard D, Binienda Z, Paule M. Introducing Black-Gold II, a highly soluble gold phosphate complex with several unique advantages for the histochemical localization of myelin. Brain Res. 2008; 1229:210-7. https://doi.org/10.1016/j.brainres.2008.06.129
81. Turati L, Moscatelli M, Mastropietro A, Dowell NG, Zucca I, Erbetta A, Cordiglieri C, Brenna G, Bianchi B, Mantegazza R, Cercignani M, Baggi F, Minati L. In vivo quantitative magnetization transfer imaging correlates with histology during de-and remyelination in cuprizone-treated mice. NMR Biomed. 2015; 28:327-37. https://doi.org/10.1002/nbm.3253
82. Flügel A, Willem M, Berkowicz T, Wekerle H. Gene transfer into CD4+ T lymphocytes: Green fluorescent protein-engineered, encephalitogenic T cells illuminate brain autoimmune responses. Nat Med. 1999; 5:843-47. https://doi.org/10.1038/10567
83. Kawakami N, Nägerl UV, Odoardi F, Bonhoeffer T, Wekerle H, Flügel A. Live imaging of effector cell trafficking and autoantigen recognition within the unfolding autoimmune encephalomyelitis lesion. J Exp Med. 2005; 201:1805-14. https://doi.org/10.1084/jem.20050011